Zoetis (ZTS) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $33.3B

Zoetis reported revenue of $9.5B in fiscal 2025, up 7.6% a year over 9 years.

Net income was $2.7B.

Free cash flow was $2.3B, and the company returned $3.2B in net buybacks.

The diluted share count fell 11% over the period (buybacks).

Revenue and free cash flow

Fiscal years, $ billions.

02.557.5102016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Zoetis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$4.9B$5.3B$5.8B$6.3B$6.7B$7.8B$8.1B$8.5B$9.3B$9.5B
Cost of revenue$1.7B$1.8B$1.9B$2.0B$2.1B$2.3B$2.5B$2.6B$2.7B$2.7B
Gross profit$3.2B$3.5B$3.9B$4.3B$4.6B$5.5B$5.6B$6.0B$6.5B$6.8B
Research and development$376M$382M$432M$457M$463M$508M$539M$614M$686M$698M
Selling, general and admin$1.4B$1.3B$1.5B$1.6B$1.7B$2.0B$2.0B$2.2B$2.3B$2.4B
Interest expense$166M$175M$206M$223M$231M$224M$221M$239M$225M$222M
Pre-tax income$1.2B$1.5B$1.7B$1.8B$2.0B$2.5B$2.7B$2.9B$3.1B$3.4B
Income tax$409M$663M$266M$301M$360M$454M$545M$596M$637M$687M
Net income$821M$864M$1.4B$1.5B$1.6B$2.0B$2.1B$2.3B$2.5B$2.7B
EPS (diluted)$1.65$1.75$2.93$3.11$3.42$4.27$4.49$5.07$5.47$6.02
Diluted shares498M493M487M482M479M477M470M462M455M444M
Gross margin65.9%66.6%67.2%68.2%69.2%70.4%69.6%70.0%70.6%71.8%
Net margin16.8%16.3%24.5%24.0%24.5%26.2%26.2%27.4%26.9%28.2%

Balance sheet

Fiscal years, from Zoetis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$727M$1.6B$1.7B$1.9B$3.6B$3.5B$3.6B$2.0B$2.0B$2.5B
Receivables$913M$998M$1.0B$1.1B$1.0B$1.1B$1.2B$1.3B$1.3B$1.4B
Inventory$1.5B$1.4B$1.4B$1.4B$1.6B$1.9B$2.3B$2.6B$2.3B$2.5B
Total current assets$3.4B$4.2B$4.4B$4.7B$6.6B$6.9B$7.5B$6.3B$6.0B$6.8B
Property, plant and equipment$1.4B$1.4B$1.7B$1.9B$2.2B$2.4B$2.8B$3.2B$3.4B$3.7B
Goodwill$1.5B$1.5B$2.5B$2.6B$2.7B$2.7B$2.7B$2.8B$2.7B$2.8B
Total assets$7.6B$8.6B$10.8B$11.5B$13.6B$13.9B$14.9B$14.3B$14.2B$15.5B
Total current liabilities$1.1B$1.1B$1.2B$1.8B$2.2B$1.8B$3.2B$1.9B$3.4B$2.2B
Long-term debt$4.5B$5.0B$6.4B$5.9B$6.6B$6.6B$6.6B$6.6B$5.2B$9.0B
Total liabilities$6.2B$6.8B$8.6B$8.8B$9.8B$9.4B$10.5B$9.3B$9.5B$12.1B
Shareholders' equity$1.5B$1.8B$2.2B$2.7B$3.8B$4.5B$4.4B$5.0B$4.8B$3.4B
Net debt$3.7B$3.4B$4.8B$4.5B$3.6B$3.1B$4.3B$4.5B$4.6B$6.6B

Cash flow

Fiscal years, from Zoetis's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow$713M$1.3B$1.8B$1.8B$2.1B$2.2B$1.9B$2.4B$3.0B$2.9B
Capital spending$216M$224M$338M$460M$453M$477M$586M$732M$655M$621M
Free cash flow$497M$1.1B$1.5B$1.3B$1.7B$1.7B$1.3B$1.6B$2.3B$2.3B
Stock-based compensation$37M$44M$53M$67M$59M$58M$62M$60M$74M$83M
Share buybacks (net)-$300M-$500M-$698M-$626M-$250M-$743M-$1.6B-$1.1B-$1.9B-$3.2B
Net borrowing-$405M-$750M$8M-$9M-$496M-$604M$2M-$1.3B-$3M-$1.4B
Free cash flow margin10.2%21.1%24.9%21.3%25.1%22.3%16.4%19.0%24.8%24.1%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ZTS.
Open ZTS in Investingly

Questions

What was Zoetis's revenue in 2025?

$9.5B in fiscal 2025, from its 10-K filing.

How much free cash flow does Zoetis generate?

$2.3B in fiscal 2025 (operating cash flow minus capital spending).

From Zoetis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.